CompletedPhase 1NCT00968162

Sickle Cell Disease Conditioning for Bone Marrow Transplant

Studying Sickle cell anemia

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Emory University
Principal Investigator: John Horan, MD
Emory University
Intervention: fludarabine(drug)
Enrollment: 8 target
Eligibility: 18 years · All sexes
Timeline: 2009 – 2016

Study locations (10)

University of Alabama-Birmingham, Birmingham, Alabama, United States
Children's National Medical Center, Washington D.C., District of Columbia, United States
All Children's Research Institute Inc., St. Petersburg, Florida, United States
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Tulane University, New Orleans, Louisiana, United States
Wayne State University, Detroit, Michigan, United States
University of Mississippi Medical Center, Jackson, Mississippi, United States
Montefiore Medical Center, The Bronx, New York, United States
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
University of Texas Southwestern, Dallas, Texas, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00968162 on ClinicalTrials.gov

Other trials for Sickle cell anemia

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell anemia →

← Back to all trials